MDI has made significant expansion to their Single Use portfolio offering a wide range of custom single use capabilities from single use bags from 50 ml- 2000 L with their new GMP qualified Aseptigold Bag film. Throughout the pandemic many suppliers have struggled due to long lead times, lack of expanded capacity and massive orders from large companies to try to secure 1 or 2 year supply. This has lead to the overall breakdown of the Biotech Industry supply chain and also revealed how a pandemic can uncover gaps in supply chain and capacity with some of the major suppliers. As the Biotech Industry rapidly shifts from stainless steel to custom single use technology for bioprocessing the accelerated demand in this area has revealed a need for new suppliers to provide additional capacity. MDI has plenty of clean room capacity and has undertaken some strategic initiatives to lower lead times for custom single use assembly to 8-10 weeks assuming subcomponents are available. MDI has leveraged their plastics injection molding capability to manufacture key components such as sanitary polypropylene fittings, reducers, quick disconnects and other key fittings that are critical to the single use assembly supply chain. They also have the unique advantage of being able to control their own filtration product supply chain which allows them to easily integrate any type of filtration components with a wide range of membranes PES, PVDF, PTFE just to name a few options. Given they have many components vertically integrated under their own manufacturing house this allows MDI to significantly reduce lead times and consistently maintain 8-10 week times during the pandemic. Given companies are far out with lead times anywhere from 25-52 weeks this is a massive advantage in the single use market place. They have also made significant investments in their single use quality programs and are actively involved in continuous improvement projects to improve quality. One example of this is they have recently completed extractables/leachables studies according to the BPOG guidance standards for both their bag film and filtration products. Considered by many experts in the industry as the most stringent and comprehensive testing protocol the BPOG standard has been adopted by many companies as the new industry standard for extractables/leachables testing in the Biotech industry. Many companies are now evaluating their single use capabilities and are surprised by the wide range of capabilities and high level of quality which is the reason their business is seeing substantial growth in 2022. They are an emerging supplier that should seriously be considered by new and established companies looking to diversify their supply chain and lower supply chain risk in the future.